Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Claudepierre

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Rheumatology (Oxford, England)|April 11, 2026
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis AtlasSandrine Jousse-Joulin, Maria A D'agostino, Gael Mouterde, et al.
Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
JAMA|September 23, 2016
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical TrialJacques-Eric Gottenberg, Olivier Brocq, Aleth Perdriger, et al.
JAMA Network Open|October 18, 2021
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Erica J Brenner, Satveer K Mahil, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Rheumatology (Oxford, England)|April 11, 2026
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis AtlasSandrine Jousse-Joulin, Maria A D'agostino, Gael Mouterde, et al.
Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
JAMA|September 23, 2016
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical TrialJacques-Eric Gottenberg, Olivier Brocq, Aleth Perdriger, et al.
JAMA Network Open|October 18, 2021
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Erica J Brenner, Satveer K Mahil, et al.
Pageof 16